New patent expiration for Bracco drug KINEVAC
Annual Drug Patent Expirations for KINEVAC Kinevac is a drug marketed by Bracco and is included in one NDA. It […]
Annual Drug Patent Expirations for KINEVAC Kinevac is a drug marketed by Bracco and is included in one NDA. It […]
IXEMPRA KIT (ixabepilone) R-pharm us llc Patent: RE41393 Expiration: Aug 8, 2022 See More … For more information on how
Drug Patent Expirations for the Week of August 7, 2022 Read Post »
Annual Drug Patent Expirations for EDURANT Edurant is a drug marketed by Janssen Prods and is included in one NDA.
New patent expiration for Janssen Prods drug EDURANT Read Post »
Annual Drug Patent Expirations for JULUCA Juluca is a drug marketed by Viiv Hlthcare and is included in one NDA.
New patent expiration for Viiv Hlthcare drug JULUCA Read Post »
Annual Drug Patent Expirations for ODEFSEY Odefsey is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug ODEFSEY Read Post »
Annual Drug Patent Expirations for COMPLERA Complera is a drug marketed by Gilead Sciences Inc and is included in one
New patent expiration for Gilead Sciences drug COMPLERA Read Post »
Annual Drug Patent Expirations for IXEMPRA+KIT Ixempra Kit is a drug marketed by R-pharm Us Llc and is included in
New patent expiration for R-pharm Us drug IXEMPRA KIT Read Post »
Annual Drug Patent Expirations for DUAKLIR+PRESSAIR Duaklir Pressair is a drug marketed by Covis and is included in one NDA.
New patent expiration for COVIS drug DUAKLIR PRESSAIR Read Post »
Annual Drug Patent Expirations for TUDORZA+PRESSAIR Tudorza Pressair is a drug marketed by Covis and is included in one NDA.
New patent expiration for COVIS drug TUDORZA PRESSAIR Read Post »
Get fresh news and insights, drug patent expirations & more…